Llwytho...
Immunotherapy for Colorectal Cancer
The recent success of anti-PD1 drugs in metastatic colorectal cancer patients with mismatch repair deficiency generated overwhelming enthusiasm for immunotherapy in the disease. However, patients with mismatch repair deficient colorectal cancer represent only a small subset of the metastatic populat...
Wedi'i Gadw mewn:
Cyhoeddwyd yn: | Cancers (Basel) |
---|---|
Prif Awduron: | , |
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
MDPI
2017
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5447960/ https://ncbi.nlm.nih.gov/pubmed/28492495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers9050050 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|